Quantitative DNA methylation analysis of laser capture microdissected formalin-fixed and paraffin-embedded tissues

Experimental and Molecular Pathology

Volumn 88, Issue 1, 2010, Pages 184-189

  Gagnon, Jean François ^a,b   Sanschagrin, François ^a,b   Jacob, Simon ^a,b   Tremblay, Andrée Anne ^a,b   Provencher, Louise ^a,b   Robert, Jean ^a,b   Morin, Carol ^a,b   Diorio, Caroline ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Breast cancer; DNA methylation; Laser capture microdissection; Methylation sensitive restriction enzyme; TIMP3; uPA

Indexed keywords

CELL DNA; FORMALDEHYDE; PARAFFIN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UROKINASE;

ACCURACY; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; EMBEDDING; ENZYME PURIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; POLYMERASE CHAIN REACTION; PROMOTER REGION; QUANTITATIVE ANALYSIS; RESTRICTION MAPPING; TISSUE FIXATION; VALIDITY;

EID: 74749102185     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.09.020     Document Type: Article

References (25)

1. Aitchison A., et al. RASSF1A promoter methylation is frequently detected in both pre-malignant and non-malignant microdissected prostatic epithelial tissues. Prostate 67 (2007) 638-644
2. Bruce S., et al. Restriction site-specific methylation studies of imprinted genes with quantitative real-time PCR. Clin. Chem. 54 (2008) 491-499
3. Cui J., et al. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46 (2001) 249-256
4. Davidson J.M., et al. Molecular cytogenetic analysis of breast cancer cell lines. Br. J. Cancer 83 (2000) 1309-1317
5. Fleiss J.L. The Design and Analysis of Clinical Experiments: Reliability of Measurement (1986), Wiley, New York
6. Gilbert M.T., et al. The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when?. PLoS ONE 2 (2007) e537
7. Grunau C., et al. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 29 (2001) E65-5
8. Hashimoto K., et al. Improved quantification of DNA methylation using methylation-sensitive restriction enzymes and real-time PCR. Epigenetics 2 (2007) 86-91
9. Hegi M.E., et al. Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J. Clin. Oncol. 26 (2008) 4189-4199
10. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21 (1999) 163-167
11. Jovanovic L., et al. Optimising restriction enzyme cleavage of DNA derived from archival histopathological samples: an improved HUMARA assay. Pathology 35 (2003) 70-74
12. Kubista M., et al. The real-time polymerase chain reaction. Mol. Aspects Med. 27 (2006) 95-125
13. Liu M.C., et al. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer. Cancer Lett. 247 (2007) 91-97
14. Mill J., et al. Whole genome amplification of sodium bisulfite-treated DNA allows the accurate estimate of methylated cytosine density in limited DNA resources. Biotechniques 41 (2006) 603-607
15. Millar D.S., et al. Methylation sequencing from limiting DNA: embryonic, fixed, and microdissected cells. Methods 27 (2002) 108-113
16. Mylona E., et al. Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome. Breast Cancer Res. 8 (2006) R57
17. Oakes C.C., et al. Evaluation of a quantitative DNA methylation analysis technique using methylation-sensitive/dependent restriction enzymes and real-time PCR. Epigenetics 1 (2006) 146-152
18. Ogino S., et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J. Mol. Diagn. 8 (2006) 209-217
19. Pakneshan P., et al. Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma. Clin. Cancer Res. 10 (2004) 3035-3041
20. Reiss, R. A., Rutz, B., 1999. Quality control PCR: a method for detecting inhibitors of Taq DNA polymerase. Biotechniques. 27, 920-2, 924-6.
21. Shen L., and Waterland R.A. Methods of DNA methylation analysis. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 576-581
22. Stingl J., and Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer 7 (2007) 791-799
23. Umetani N., et al. Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase. Biochem. Biophys. Res. Commun. 329 (2005) 219-223
24. Watson M.B., et al. Chromosomal alterations in breast cancer revealed by multicolour fluorescence in situ hybridization. Int. J. Oncol. 25 (2004) 277-283
25. Yang W.H., et al. Methylation profiling using degenerated oligonucleotide primer-PCR specific for genome-wide amplification of bisulfite-modified DNA. Anal. Biochem. 369 (2007) 120-127